Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer.

Gynecologic oncology

Volumn 134, Issue 3, 2014, Pages 473-477

  Fairfield, Kathleen M ^a   Murray, Kimberly ^a   LaChance, Jason A ^a   Wierman, Heidi R ^a   Earle, Craig C ^a   Trimble, Edward L ^a   Warren, Joan L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; DISPARITIES; FEMALE; HEALTH CARE DISPARITY; HUMAN; INFUSION; INTRAPERITONEAL CHEMOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MEDICARE; NEOPLASM; OVARY CANCER; OVARY TUMOR; STATISTICS; UNITED STATES;

DISPARITIES; INTRAPERITONEAL CHEMOTHERAPY; OVARIAN CANCER;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; MEDICARE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; UNITED STATES;

EID: 84908377383     PISSN: None     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.06.011     Document Type: Article

References (0)